Zhang, L., Li, R., Zhang, J., Li, J., Nie, N., Li, X., Yu, X., Kuang, Z., Li, L., Zhao, J., Rosario, M. D., Shi, X., Yu, Y., Zhou, Y., Gao, M., Ge, W., Ren, J., Davidson-Moncada, J., Shi, J. (2025). A Phase I, open-label study of CTD402, a universal CD7-targeting CAR T-cell therapy, in patients with relapsed/refractory severe aplastic anemia. Blood. https://doi.org/10.1182/blood-2025-3210